PharmaOpinionOpenAI Wants to “Accelerate” the Work Behind New Drugs
The acquisition moves OpenAI into software coordinating drug programs, as pharma buyers seek AI that connects research, budgets and execution.
Greg Brockman
Deployed's enterprise AI reporting on Greg Brockman.
Related deployments
PharmaOpinion
ManufacturingOpenAI Strikes Again, Intel’s AI Head Joins the ChatGPT Movement
Intel’s AI chief, Sachin Katti, leaves to join OpenAI, as CEO Lip-Bu Tan steps in to take direct control of AI efforts.
BankingLeadership moveOpenAI Appoints Mike Liberatore as Business Finance Officer
Scaling infrastructure requires careful financial management. Mike’s experience will support these operations while aligning strategic priorities with operational capabilities.